Simple Score to Predict Treatment Response to Low-Dose Tolvaptan in Patients with Heart Failure
Author:
Affiliation:
1. Department of Cardiovascular Medicine and Endocrinology and Metabolism, Faculty of Medicine, Tottori University
Publisher
International Heart Journal (Japanese Heart Journal)
Subject
Cardiology and Cardiovascular Medicine,General Medicine
Link
https://www.jstage.jst.go.jp/article/ihj/63/2/63_21-558/_pdf
Reference15 articles.
1. 1. Konstam MA, Gheorghiade M, Burnett JC Jr, et al. Effects of oral Tolvaptan in patients hospitalized for worsening heart failure: The Everest Outcome Trial. JAMA 2007; 297: 1319-31.
2. 2. Gheorghiade M, Konstam MA, Burnett JC Jr, et al. Short-term clinical effects of Tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: The Everest Clinical Status Trials. JAMA 2007; 297: 1332-43.
3. 3. Kuragaichi T, Sato Y. Temporal trends of a vasopressin V2 receptor antagonist in heart failure using a nationwide database in Japan. ESC Heart Fail 2021; 8: 527-38.
4. 4. Kinugawa K, Sato N, Inomata T, Shimakawa T, Iwatake N, Mizuguchi K. Efficacy and safety of Tolvaptan in heart failure patients with volume overload. Circ J 2014; 78: 844-52.
5. 5. Statement on the appropriate use of vasopressin V2 receptor antagonists, joint statement by the Japanese Circulation Society and the Japanese Heart Failure Society. Available at: http://www.j-circ.or.jp/information/20131021_statement. Accessed April 22, 2021.
Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Reply to Letter Regarding Article, "Simple Score to Predict Treatment Response to Low-Dose Tolvaptan in Patients with Heart Failure";International Heart Journal;2022-09-30
2. Letter by Nakagawa, <i>et al</i>. Regarding Article, "Simple Score to Predict Treatment Response to Low-Dose Tolvaptan in Patients with Heart Failure";International Heart Journal;2022-09-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3